Physiomics Banner Image


  • Ticker PYC
    Exchange LSE More
  • Industry Biotechnology More
  • Sector Healthcare More
Physiomics Logo Image
  • 1-10 Employees
  • Based in Oxford, England
Physiomics plc combines systems biology, PKPD and cutting edge mathematics to develop models that streamline the drug discovery and development process. Virtual Tumour, the company’s lead service, is used to optimise the dosing and scheduling of oncology drugs in pre-clinical and clinical trials. This optimisation improves the efficacy of combinations and streamlines the drug developmentMore process. The Company has worked in the small molecule as well as the biological space and has experience of traditional chemo, targeted chemo and immuno-therapies.

Most Recent Annual Report

MOST RECENT 2021 Annual Report

Older/Archived Annual Reports